MoneyWorks4Me

The company witnessed a 13.01% growth in the revenue at Rs. 22039.20 millions for the quarter ended June 2022 as compared to Rs. 19501.60 millions during the year-ago period.A good growth in profit of 25.30% reported to Rs. 6916.10  millions over Rs. 5519.70 millions of corresponding previous quarter.Operating profit for the quarter ended June 2022 rose to 9275.70 millions as compared to 8870.20 millions of corresponding quarter ended June 2021.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 22039.20 19501.60 13.01 22039.20 19501.60 13.01 88798.20 67986.10 30.61
Other Income 899.90 355.50 153.14 899.90 355.50 153.14 1112.60 625.30 77.93
PBIDT 9275.70 8870.20 4.57 9275.70 8870.20 4.57 39877.20 28832.10 38.31
Interest 1.00 2.40 -58.33 1.00 2.40 -58.33 6.50 6.90 -5.80
PBDT 9274.70 8867.80 4.59 9274.70 8867.80 4.59 39870.70 28825.20 38.32
Depreciation 834.20 730.10 14.26 834.20 730.10 14.26 3105.50 2546.50 21.95
PBT 8440.50 8137.70 3.72 8440.50 8137.70 3.72 36765.20 26278.70 39.90
TAX 1524.40 2618.00 -41.77 1524.40 2618.00 -41.77 7279.80 6731.50 8.15
Deferred Tax 148.10 223.20 -33.65 148.10 223.20 -33.65 907.80 641.00 41.62
PAT 6916.10 5519.70 25.30 6916.10 5519.70 25.30 29485.40 19547.20 50.84
Equity 530.90 530.90 0.00 530.90 530.90 0.00 530.90 530.90 0.00
PBIDTM(%) 42.09 45.48 -7.47 42.09 45.48 -7.47 44.91 42.41 5.89
Peers
Company Name CMP
Sun Pharma. Inds. 1759.10
Dr. Reddys Labs. 1230.50
Cipla 1313.70
Lupin 1946.00
Zydus Lifesciences 1139.00
View more..